• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form 10-K/A filed by Albemarle Corporation

    3/31/25 4:20:28 PM ET
    $ALB
    Major Chemicals
    Industrials
    Get the next $ALB alert in real time by email
    alb-20241231
    false2024FY0000915913iso4217:USDxbrli:shares00009159132024-01-012024-12-310000915913us-gaap:CommonStockMember2024-01-012024-12-310000915913us-gaap:SeriesAPreferredStockMember2024-01-012024-12-3100009159132024-06-2800009159132025-02-05

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ________________________________________

    FORM 10-K/A
    (Amendment No. 1)
    ________________________________________
    ☒Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the fiscal year ended December 31, 2024

    or
    ☐
    Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the transition period from                      to                     
    Commission file number 001-12658
    ALBEMARLE CORPORATION
    (Exact name of registrant as specified in its charter)
    Virginia54-1692118
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification No.)
    4250 Congress Street, Suite 900
    Charlotte, North Carolina 28209
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (980) - 299-5700
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    COMMON STOCK, $.01 Par ValueALBNew York Stock Exchange
    DEPOSITARY SHARES, each representing a 1/20th interest in a share of 7.25% Series A Mandatory Convertible Preferred StockALB PR ANew York Stock Exchange
    Securities registered pursuant to Section 12(g) of the Act: None
    Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☒    No  ☐
    Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐ No  ☒
    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days.    Yes  ☒    No  ☐
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☒    No  ☐
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”



    “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☒Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
    Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
    If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
    Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐ No  ☒
    The aggregate market value of the voting and non-voting common equity stock held by non-affiliates of the registrant was approximately $11.2 billion based on the last reported sale price of common stock on June 28, 2024, the last business day of the registrant’s most recently completed second quarter.
    Number of shares of common stock outstanding as of February 5, 2025: 117,573,461
    Documents Incorporated by Reference
    Portions of Albemarle Corporation’s definitive Proxy Statement for its 2025 Annual Meeting of Shareholders filed with the U.S. Securities and Exchange Commission on March 27, 2025 pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended, are incorporated by reference into Part III of this Annual Report on Form 10-K.





    EXPLANATORY NOTE

    On February 12, 2025, Albemarle Corporation (“Albemarle” or the “Company”) filed its Annual Report on Form 10-K for the year ended December 31, 2024 with the Securities and Exchange Commission (the “Original Filing”).
    This Amendment No. 1 to Form 10-K (“Amendment No. 1”) of Albemarle is being filed solely to amend Item 15(c) of Part IV of the Original Filing to include the separate financial statements of Windfield Holdings Pty Ltd (“Windfield”) as required under Rule 3-09 of Regulation S-X (“Rule 3-09”). The financial statements of Windfield for its fiscal year ended December 31, 2024 were not available at the time the Company filed the Original Filing. The required financial statements are now provided as Exhibit 99.1 to this Amendment No. 1.
    Windfield was significant under Rule 3-09 for the fiscal years ended December 31, 2023 and 2022, but not for the fiscal year ended December 31, 2024. As a result, under Rule 3-09, we have included in this Amendment No. 1 unaudited consolidated financial statements for the fiscal year ended December 31, 2024 and audited consolidated financial statements for the years ended December 31, 2023 and 2022.
    Part IV, Item 15 is the only portion of the Company’s Annual Report on Form 10-K being supplemented or amended by this Form 10-K/A. This Amendment No. 1 also updates, amends and supplements Part IV, Item 15 of the Original Filing to include, among other items, the filing of new Exhibits 31.1, 31.2, 32.1 and 32.2, certifications of our Chief Executive Officer and Chief Financial Officer, pursuant to Rules 13a-14(a) and (b) of the Securities Exchange Act of 1934, as amended. This Amendment No. 1 does not change any other information set forth in the Original Filing. This Amendment No. 1 consists solely of the preceding cover page, this explanatory note, the information required by Item 15(c) of Form 10-K as provided in Exhibit 99.1, a signature page, the accountants’ consent for Windfield and certifications required to be filed as exhibits hereto.




    PART IV
    Item 15.Exhibits and Financial Statement Schedules.
    (a)(1) The following consolidated financial and informational statements of the registrant are included in Part II Item 8 of the Company’s Annual Report on Form 10-K filed on February 12, 2025:
    Management’s Report on Internal Control Over Financial Reporting
    Report of Independent Registered Public Accounting Firm (PricewaterhouseCoopers LLP, Charlotte, North Carolina, PCAOB ID 238)
    Consolidated Balance Sheets as of December 31, 2024 and 2023
    Consolidated Statements of Income, Comprehensive Income, Changes in Equity and Cash Flows for the years ended December 31, 2024, 2023 and 2022
    Notes to the Consolidated Financial Statements
    (a)(2) No Financial Statement Schedules are provided in accordance with Item 15(a)(2) as the information is either not applicable, not required or has been furnished in the Consolidated Financial Statements or Notes thereto.
    (a)(3)Exhibits
    The following documents are filed as exhibits to this Annual Report on Form 10-K/A (Amendment No.1) pursuant to Item 601 of Regulation S-K. These exhibits should be read in conjunction with Item 15 of the Company’s Annual Report on Form 10-K filed on February 12, 2025:
    *23.7
    Consent of KPMG.
    *31.1
    Certification of Principal Executive Officer pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended.
    *31.2
    Certification of Principal Financial Officer pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended.
    *32.1
    Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
    *32.2
    Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
    *99.1
    Financial Statements of Windfield Holdings Pty Ltd for the year ended December 31, 2024.
    *101
    Interactive Data Files (Annual Report on Form 10-K, for the fiscal year ended December 31, 2024, furnished in XBRL (eXtensible Business Reporting Language)).
    *104Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
    *Included with this filing.
    (c) The financial statements of Windfield Holdings Pty Ltd included in Exhibit 99.1 for the year ended December 31, 2024 are filed as part of Item 15 of the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and should be read in conjunction with the Company's consolidated financial statements filed with the Company’s Annual Report on Form 10-K filed on February 12, 2025.


    Albemarle Corporation and Subsidiaries
    SIGNATURES
    Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
    ALBEMARLE CORPORATION
    (Registrant)
    By:
    /S/    J. KENT MASTERS   
    (J. Kent Masters)
    Chairman, President and Chief Executive Officer
    Dated: March 31, 2025


    Get the next $ALB alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ALB

    DatePrice TargetRatingAnalyst
    7/11/2025$57.00Neutral → Sell
    UBS
    2/5/2025Outperform → In-line
    Evercore ISI
    1/28/2025$96.00Hold
    Truist
    1/14/2025$112.00Buy
    Clarksons Platou
    8/5/2024$102.00 → $85.00Outperform → Neutral
    Robert W. Baird
    7/31/2024$160.00 → $83.00Buy → Hold
    Berenberg
    7/17/2024$95.00Buy → Hold
    HSBC Securities
    7/11/2024$145.00 → $100.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $ALB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Oconnell Diarmuid B. was granted 2,762 shares, increasing direct ownership by 50% to 8,233 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      7/3/25 3:35:31 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Director Brlas Laurie was granted 2,762 shares, increasing direct ownership by 85% to 6,003 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      7/3/25 3:34:59 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Director Obrien James J /Ky was granted 2,762 shares, increasing direct ownership by 52% to 8,085 units (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      7/3/25 3:34:36 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

      CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

      6/18/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Publishes 2024 Sustainability Report, Updates Efforts to Reduce Carbon Footprint, Manage Freshwater Responsibly and Support Customers' Sustainability Goals

      CHARLOTTE, N.C., June 3, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today published its 2024 Sustainability Report. Entitled Values-Led, Purpose-Driven, the report provides an update on Albemarle's achievements in line with the company's sustainability goals.   "As a values-led organization, sustainability is foundational to how we choose to operate," said Albemarle Chairman and CEO Kent Masters. "The initiatives outlined in this report speak to our commitment to creating a more resilient world. We remain dedicated to minimizing our environmental footprint,

      6/3/25 6:55:00 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    SEC Filings

    See more
    • SEC Form 11-K filed by Albemarle Corporation

      11-K - ALBEMARLE CORP (0000915913) (Filer)

      6/26/25 4:18:33 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SD filed by Albemarle Corporation

      SD - ALBEMARLE CORP (0000915913) (Filer)

      6/2/25 4:19:31 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - ALBEMARLE CORP (0000915913) (Filer)

      5/9/25 4:24:16 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Coleman Kristin M. bought $167,314 worth of shares (1,373 units at $121.86) (SEC Form 4)

      4 - ALBEMARLE CORP (0000915913) (Issuer)

      11/7/23 4:39:49 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Albemarle downgraded by UBS with a new price target

      UBS downgraded Albemarle from Neutral to Sell and set a new price target of $57.00

      7/11/25 8:09:46 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle downgraded by Evercore ISI

      Evercore ISI downgraded Albemarle from Outperform to In-line

      2/5/25 9:17:34 AM ET
      $ALB
      Major Chemicals
      Industrials
    • Truist initiated coverage on Albemarle with a new price target

      Truist initiated coverage of Albemarle with a rating of Hold and set a new price target of $96.00

      1/28/25 7:08:44 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Leadership Updates

    Live Leadership Updates

    See more
    • Ketjen Announces the Appointment of Henri Tausch as Chief Commercial Officer

      Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing, today announces the appointment of Henri Tausch to Chief Commercial Officer (CCO) effective June 24, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619765799/en/Henri Tausch, Ketjen Chief Commercial Officer (Photo: Business Wire) In his role as Chief Commercial Officer, Tausch will oversee and advance the company's commercial strategy, and foster key partnerships to accelerate the company's global growth trajectory. "I am honored to join Ketjen and contribute to its continued success," said Henri Tausch "It's inspiring to see Ketjen's dedi

      6/19/24 7:00:00 AM ET
      $ALB
      Major Chemicals
      Industrials
    • International Paper Announces Changes to Its Board of Directors

       Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

      5/23/24 10:51:00 AM ET
      $ALB
      $AVNT
      $IP
      Major Chemicals
      Industrials
      Paper
      Basic Materials
    • Albemarle Reports Net Sales Increase of 60% for Second Quarter 2023

      CHARLOTTE, N.C., Aug. 2, 2023 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the second quarter ended June 30, 2023. Second-Quarter 2023 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $2.4 billion, an increase of 60%Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%Adjusted diluted EPS of $7.33, an increase of 112%Adjusted EBITDA of $1.0 billion, an i

      8/2/23 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      12/5/24 7:27:01 PM ET
      $ALB
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by Albemarle Corporation

      SC 13G - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 12:52:42 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Albemarle Corporation

      SC 13G/A - ALBEMARLE CORP (0000915913) (Subject)

      11/13/24 10:27:59 AM ET
      $ALB
      Major Chemicals
      Industrials

    $ALB
    Financials

    Live finance-specific insights

    See more
    • Albemarle Corporation to Release Second Quarter 2025 Earnings Results on Wednesday, July 30, 2025

      CHARLOTTE, North Carolina, June 18, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that it will release its second quarter 2025 earnings after the NYSE closes on Wednesday, July 30, 2025. The company will hold a conference call to discuss its second quarter 2025 results on Thursday, July 31, at 8 a.m. ET. Access to the call is available via webcast or direct dial. A link to the webcast can be found through Albemarle Corporation's website at http://investors.al

      6/18/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Announces 126th Consecutive Quarterly Common Stock Dividend

      CHARLOTTE, N.C., May 6, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE:ALB) announced today that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025. About AlbemarleAlbemarle Corp. (NYSE:ALB) leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. We partner to

      5/6/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials
    • Albemarle Reports First Quarter 2025 Results

      CHARLOTTE, N.C., April 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE:ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced its results for the first quarter ended March 31, 2025. First-Quarter 2025 and Recent Highlights(Unless otherwise stated, all percentage changes represent year-over-year comparisons) Net sales of $1.1 billion, with double-digit volume growth in Specialties (+11%) and record Energy Storage lithium salt production from the company's integrated conversion networkNet income of $41 million, o

      4/30/25 4:15:00 PM ET
      $ALB
      Major Chemicals
      Industrials